What is the revenue and EPS growth rate for Ventas year over year?

What were the key takeaways from Ventas’s earnings call?

What is Ventas's latest dividend and current dividend yield?

What is the market's earnings forecast for Ventas next quarter?

What factors drove the changes in Ventas's revenue and profit?

What is Ventas's gross profit margin?

What guidance did Ventas's management provide for the next earnings period?

What does Ventas do and what are its main business segments?

- **Senior Housing Growth**: 15% same-store NOI in 2025, 13-17% 2026 guidance, and $2.5 billion investments.
- **Demographic Tailwind**: 28% growth in over-80 population over 5 years, with 2 million turning 80 in 2026.
- **Financial Strength**: 9% FFO growth in 2025, 8% 2026 guidance, and 5.2x leverage.
- **Operational Excellence**: 50% incremental margin, 8% RevPOR increases, and 270 bps occupancy growth.
- **Competitive Position**: 83,000+ units, 43 operators, and sub-7% cap rates on new acquisitions.

**【CEO Summary Section】**
- Ventas delivered 9% normalized FFO per share growth in 2025, driven by senior housing (SHOP) with 15% same-store NOI growth.
- 2026 guidance includes 8% FFO growth, 10% same-store NOI growth, and $2.5 billion in senior housing investments.
- The company targets the over-80 population, expecting 28% growth in this demographic over the next 5 years.
- Ventas OI platform enables 50% incremental margin, with 2026 RevPOR increases of 8% and 5% operating leverage.

**【CFO Financial Commentary】**
- 2025 normalized FFO of $3.48 per share, up 9% YoY, with $7 billion in capital raised and leverage at 5.2x.
- 2026 guidance: $3.78-$3.88 FFO per share (midpoint +8%), $2.5 billion equity-funded investments, and 4% triple-net rent escalators.
- G&A expenses to grow in line with enterprise, with $150 million in incremental costs for platform expansion.

**【Q&A Highlights】**
- **Acquisition Pipeline**: $2.5 billion 2026 target, 80%+ repeat seller transactions, and sub-7% cap rates on new deals.
- **Occupancy Trends**: U.S. SHOP at 86% occupancy, 270 bps YoY growth in 2026, and 7x affordability ratio vs. in-home care costs.
- **Competitive Advantage**: 83,000+ SHOP units, 43 operators, and Ventas OI platform driving 50%+ incremental margins.
- **Development Risk**: Rents need 20-30%+ increases for new supply, with ultra-premium products likely first to market.
- **Balance Sheet**: $12 billion unsettled equity, 5x leverage target, and $2.2 billion debt refinanced in 2026.

Ventas, Inc. (VTR) Q4 2025 Earnings Call Transcript

- **Record Growth**: 10% YoY increase in normalized FFO per share, driven by 19% Same-Store NOI growth in U.S. senior housing.
- **Expanded Guidance**: Full-year FFO guidance raised to 9%, with $2.5 billion in senior housing investments.
- **Demographic Tailwind**: Over-80 population set to grow 28% over five years, fueling demand for private pay senior housing.
- **Operational Excellence**: 85% U.S. SHOP occupancy with 270 basis points YoY growth, and 50% incremental margin in high-occupancy communities.
- **Balance Sheet Strength**: Net debt to EBITDA improved to 5.3x, supporting equity-funded growth strategy.

**【CEO Summary Section】**
- Ventas delivered 10% year-over-year growth in normalized FFO per share, driven by 19% Same-Store Cash NOI growth in U.S. senior housing.
- The company raised full-year guidance to 9% normalized FFO growth and 7.5% total Same-Store NOI, citing strong SHOP performance and $2.5 billion in senior housing investments.
- Emphasized the secular tailwind of aging demographics, with the over-80 population set to grow 28% over the next five years.
- Converted 27 of 45 Triple-Net communities to SHOP, with remaining conversions expected by year-end, targeting $50 million of NOI upside.

**【CFO Financial Commentary】**
- Third-quarter normalized FFO per share was $0.88, up 10% YoY, with total Same-Store Cash NOI growth of 8%.
- Net debt to EBITDA improved to 5.3x, down 1.0x year-over-year, reflecting equity-funded investments and organic growth.
- Raised 2025 normalized FFO guidance to $3.47 per share (midpoint), driven by SHOP performance and senior housing investments.
- Research business NOI declined $0.4 million YoY due to lower flex space rents, but 87% tenant retention rate and 90.6% occupancy in outpatient medical.

**【CFO Financial Commentary】**
- Total company Same-Store Cash NOI growth of 8%, with SHOP contributing 16% growth and U.S. senior housing leading at 19%.
- Outpatient Medical and Research (OMAR) reported 3.7% NOI growth, driven by 50 basis points sequential improvement in outpatient medical occupancy.
- Research portfolio NOI declined due to lower flex space rents, but 87% tenant retention rate and 90.6% occupancy in outpatient medical.

**【Q&A Highlights】**
- **Acquisition Strategy**: Committed to $2.5 billion in senior housing investments, targeting low to mid-teens IRRs through a mix of yield and growth. No plans to lower initial yield requirements despite strong demand.
- **Leverage Management**: Maintaining equity-funded growth strategy, with net debt to EBITDA at 5.3x, down 1.0x YoY.
- **Triple-Net to SHOP Conversions**: 27 of 45 Brookdale communities converted, with remaining transitions expected by year-end. Communities performing well with 33% rent increase beginning 2026.
- **Occupancy Growth**: U.S. SHOP portfolio at 85% occupancy, with sequential growth of 160 basis points and expectations for continued improvement into Q4.
- **Competitive Advantage**: Ventas OI platform enables data-driven decision-making, supporting 40 operators and delivering 50% incremental margin in high-occupancy communities.


Ventas, Inc. (VTR) Q3 2025 Earnings Call Transcript

- **Record Growth**: 9% YoY FFO growth to $0.87, with 7% same-store NOI driven by 18% SHOP NOI expansion.
- **Investment Surge**: $2B+ senior housing investments guided for 2025, yielding 7.2% cash yield and mid-teens IRRs.
- **Balance Sheet Strength**: 5.6x net debt/EBITDA, $4.7B liquidity, and proactive debt refinancing.
- **Occupancy Momentum**: June move-ins at 5-year high, with 60bps sequential growth and July trends matching.
- **Strategic Focus**: Doubling Brookdale community NOI and targeting 95% outpatient medical occupancy.

**【CEO Opening Remarks】**
- Reported 9% year-over-year growth in normalized FFO per share to $0.87, with total company same-store cash NOI up 7%.
- Raised full-year FFO guidance midpoint to $3.44 per share (8% YoY growth) and narrowed same-store NOI growth to 7% at midpoint.
- Emphasized the 1-2-3 strategy: organic growth in Senior Housing Operating Portfolio (SHOP), accretive senior housing investments, and balanced portfolio performance.

**【CEO Strategy Update】**
- **SHOP Growth**: U.S. SHOP NOI up 18% YoY, with 8.2% revenue growth and 240bps occupancy improvement. June move-ins reached second-highest level in 5 years.
- **Investment Pipeline**: Raised 2025 senior housing investment guidance to $2B, with $1.1B closed YTD. Assets yield 7.2% in year 1 and low/mid-teens unlevered IRRs.
- **Balanced Portfolio**: Outpatient medical NOI up 2.2% YoY, with 90.1% occupancy and 1M sq.ft. of new leases. Research portfolio NOI down <1% YoY due to pre-revenue tenant challenges.

**【CFO Financial Update】**
- Q2 normalized FFO of $0.87 per share, driven by 13.3% SHOP NOI growth and 1.7% OMAR NOI growth.
- Balance sheet strength: net debt/EBITDA improved to 5.6x, liquidity at $4.7B, and $500M of 5.1% senior notes refinanced ahead of 2025 maturities.
- 2025 guidance reflects $0.02 FFO benefit from lower interest expense and $0.01 from higher investments.

**【Q&A Highlights】**
- **Occupancy Momentum**: June saw 60bps sequential occupancy growth in SHOP, with July trends matching or exceeding June levels.
- **Investment Competition**: Pipeline up 41% YoY by dollar volume, with focus on high-quality assets in fast-growing markets.
- **Operator Transitions**: 45 Brookdale communities transitioning to 5 new operators, targeting double NOI over time.
- **Healthcare Policy Impact**: Minimal near-term impact from healthcare reforms; outpatient trends may accelerate.
- **SHOP Margin Expansion**: 50-70% incremental margins expected as occupancy moves from 80-90% to 90-100%.


Ventas, Inc. (VTR) Q2 2025 Earnings Call Transcript

- **SHOP Dominance**: 14% NOI growth, 290 bps occupancy gain, and 7% rate increases highlight senior housing leadership.
- **Investment Acceleration**: $1.5B 2025 target (up 50%) reflects pipeline expansion and 7.2% NOI yield deals.
- **Canada Outperformance**: 97% occupancy with 14% NOI growth, driven by assisted living mix and regulatory easing.
- **Balance Sheet Strength**: 5.7x net debt/EBITDA, $3.6B liquidity, and proactive debt refinancing support growth.
- **Key Selling Season**: Q2 occupancy headwinds from March move-outs, but strong move-in pipeline for May-Sep.

**【CEO Opening Remarks】**
- Ventas delivered $0.84 of normalized FFO per share in Q1 2025, up 8% YoY, driven by senior housing operating portfolio.
- SHOP cash same-store NOI grew 14% YoY, with occupancy up 290 bps (U.S. +330 bps) and rate increases averaging 7%.
- Full-year guidance reaffirmed: 7% normalized FFO per share growth, with SHOP representing >50% of NOI by year-end.
- 2025 investment guidance raised to $1.5B, up from $1B, reflecting expanded pipeline and relationship-driven deals.

**【CFO Financial Update】**
- Q1 2025 normalized FFO of $0.84 per share (+8% YoY), with total same-store cash NOI +7% YoY.
- Outpatient medical (OMAR) same-store NOI +1.3% YoY, research portfolio NOI -0.3% YoY due to 30 bps occupancy decline.
- Net debt/EBITDA improved to 5.7x (vs. 6.0x YoY), with $3.6B liquidity and proactive refinancing of $1B senior notes.
- 2025 FFO midpoint of $3.41 reflects 7% growth, driven by SHOP organic growth and accretive acquisitions.

**【SHOP Operations & Investments】**
- SHOP Q1 NOI growth of 13.6% (cash basis), with revenue +7.4% (occupancy +290 bps, rate +7%), expenses +5%.
- 45 Brookdale communities transitioning to SHOP expected to double NOI over time, with new operators already outperforming legacy portfolio.
- 2025 investments of $1.5B (vs. $1B prior) focused on senior housing with 7.2% year-one NOI yields and low-to-mid-teens IRRs.
- 2.8B of acquisitions since Q2 2024, with 900M closed YTD and pipeline of $3B+.

**【Q&A Highlights】**
- **SHOP Margin Expansion**: Incremental margin of ~50% in Q1, with potential for 70%+ as occupancy approaches 100%.
- **Investment Costs**: Per-unit cost rose to $3.5M (vs. $2.7M last year) due to newer vintages and better markets, but still below replacement cost (~$4M).
- **Canada Performance**: 97% occupancy with 14% NOI growth, driven by assisted living mix and rate increases.
- **Research Portfolio**: 75% of tenants are credit-rated, with 9-10 year lease walls; 12% of space in flexible biotech space with 5-7 year leases.
- **Seasonality**: Q2 starting occupancy lower due to March clinical move-outs, but key selling season (May-Sep) expected to drive strong move-ins.


Ventas (VTR)-1 May 25-2025 Q1 Earnings call transcript

- **2024 FFO Growth Record**: 7% YoY to $3.19, beating high-end guidance. 
- **SHOP Dominance**: 43% of NOI in 2024, 50%+ by 2025 end. 2024 SHOP NOI +16%, 2025 target +13.5%. 
- **$2B+ Senior Housing Investments**: All equity funded, reducing leverage to 6.0x. 2025 pipeline >$1B. 
- **2025 Outlook**: 7% FFO growth, 6.75% NOI growth, 7% dividend increase. 
- **Key Risks**: Seasonality, inflation, and NIH funding uncertainty. 
- **Long-Term Tailwind**: 28%+ 80+ population growth, 5-year supply deficit.

**【CEO & CFO Opening Remarks】**
- Full year 2024 normalized FFO per share: $3.19 (7% YoY growth), exceeding high-end guidance. SHOP same-store cash NOI grew 16%, driven by 300bps occupancy increase and strong demand in senior housing. 
- 2025 guidance: 7% FFO per share growth (midpoint $3.41), with SHOP NOI expected to grow 11-16%.
- $2.2B in accretive senior housing investments in 2024, funded entirely by equity, reducing leverage to 6.0x (target range 5-6x). 

**【Justin Hutchens - SHOP Organic Growth】**
- 2024 results: U.S. SHOP NOI +20%, occupancy +370bps in Q4. 2025 outlook: 11-16% NOI growth (midpoint +13.5%), driven by:
  - 8% revenue growth (4.5% RevPOR, 3.5% rate increases)
  - 270bps occupancy growth
  - 5% expense control
- 45 Brookdale communities to convert to SHOP, adding 5,700 units and ~$50M annualized NOI. 

**【Justin Hutchens - External Growth】**
- 2024 investments: $1.9B in senior housing (78% year-1 NOI yield, low/mid-teens IRRs). 2025 pipeline: $1B+ with clear line of sight, weighted to H1. 
- Competitive advantage: data-driven underwriting, 29-operator network, and $5B+ VIM platform. 
- New hire: Alex Russo (Lazard veteran) to lead investments. 

**【Bob Probst - Financial Highlights】**
- 2024 results: GAAP EPS $0.19, FFO $3.19 (7% growth). 2025 FFO guidance: $3.35-3.46 (midpoint +7%). 
- Capital structure: $2.2B equity raised in 2024, $250M forward equity for 2025. 2025 net interest expense expected to rise $0.08 due to refinancing. 
- 2025 NOI growth: 6.75% (SHOP +16%, medical +3%, research +4.6%). 

**【Q&A Key Themes】**
1. **Medical Office Growth**: 2025 NOI +3% (vs. 2024 +2.6%), with 34% of 2025 leasing plan already completed. 
2. **SHOP Pricing Power**: High-occupancy communities see 30-40% RevPOR premium. 25% of portfolio below 80% occupancy. 
3. **Development Risk**: No new supply expected for 2025; RevPOR needs to rise 20-50% to justify construction. 
4. **Competitive Landscape**: Pipeline >$18B in 2024, closing 11% of reviewed deals. Maintaining 7-8% yield discipline. 
5. **Risks**: Seasonality (Q1 occupancy dips), inflation (5% expense growth), and NIH funding uncertainty (SHOP 8% of NOI).

Actual																	1.26	-0.42	0.03	0.29	-0.15	0.23	0.16	-0.1	0.1	-0.11	0	-0.11	0.04	0.26	-0.18	-0.23	-0.04	0.05	0.05	0.13	0.1	0.15	0.14	0.15
Forecast																	0.18	0.25	-0.0771	0.0756	0.02	-0.0788	0.0543	-0.03	-0.0314	0.0029	0.025	-0.0083	-0.1033	0.0217	-0.0186	-0.1643	-0.326	0.04	-0.024	0.0633	0.096	0.135	0.092	0.1007
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+600.00%	-268.00%	+138.91%	+283.60%	-850.00%	+391.88%	+194.66%	-233.33%	+418.47%	-3893.10%	-100.00%	-1225.30%	+138.72%	+1098.16%	-867.74%	-39.99%	+87.73%	+25.00%	+308.33%	+105.37%	+4.17%	+11.11%	+52.17%	+48.96%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	1.01B	943.20M	918.94M	921.16M	910.29M	919.19M	976.08M	1.02B	1.02B	1.02B	1.04B	1.05B	1.08B	1.11B	1.15B	1.16B	1.20B	1.20B	1.24B	1.29B	1.36B	1.42B	1.49B	1.57B
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	958.78M	962.62M	903.61M	914.40M	889.02M	900.56M	921.10M	957.62M	1.02B	1.04B	1.03B	1.04B	1.04B	1.09B	1.12B	1.15B	1.16B	1.19B	1.21B	1.26B	1.32B	1.38B	1.44B	1.50B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+5.56%	-2.02%	+1.70%	+0.74%	+2.39%	+2.07%	+5.97%	+6.77%	-0.52%	-1.23%	+1.17%	+0.93%	+3.63%	+1.46%	+2.82%	+1.40%	+3.11%	+0.65%	+1.99%	+2.37%	+3.23%	+3.07%	+3.62%	+4.09%

VTR

VTR fundamentals

VTR Q4 2025 Earnings

Earnings Call

You can ask Aime

VTR

VTR fundamentals

VTR Q4 2025 Earnings

Earnings Call

VTR Earnings Call Summary for Q4/202510:00 AM on Feb 6, 2026

VTR Earnings Call Summary for Q3/202510:00 AM on Oct 30, 2025

VTR Earnings Call Summary for Q2/202510:00 AM on Jul 31, 2025

VTR Earnings Call Summary for Q1/202510:00 AM on May 1, 2025

VTR Earnings Call Summary for Q4/202410:00 AM on Feb 13, 2025

You can ask Aime